|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
|
|---|---|---|---|---|---|
| Assets | |||||
| Deferred offering costs | |||||
| Current assets | |||||
| Cash | |||||
| Due from Sponsor | |||||
| Prepaid expenses | |||||
| Total current assets | |||||
| Long-term prepaid insurance | |||||
| Marketable securities held in Trust Account | |||||
| Total Assets | |||||
| Liabilities, Class A Ordinary Shares Subject to Possible Redemption, and Shareholders’ Deficit | |||||
| Current liabilities | |||||
| Accounts payable and accrued expenses | |||||
| Promissory note - related party | |||||
| Related Party | |||||
| Total promissory note - related party | |||||
| Accrued offering costs | |||||
| Total current liabilities | |||||
| Deferred underwriting fee | |||||
| Total Liabilities | |||||
| Commitments and Contingencies (Note 6) | |||||
| Class A ordinary shares subject to possible redemption, $0.0001 par value; 23,000,000 shares at redemption value of approximately $10.33 and $10.16 per share as of June 30, 2026 and December 31, 2025, respectively | |||||
| Shareholders’ Deficit | |||||
| Preference shares, $0.0001 par value; 1,000,000 shares authorized; none issued or outstanding as of June 30, 2026 and December 31, 2025 | |||||
| Ordinary shares, value issued | |||||
| Class A Ordinary Shares | |||||
| Class B Ordinary Shares | |||||
| Additional paid-in capital | |||||
| Accumulated deficit | |||||
| Total Shareholders’ Deficit | |||||
| Total Liabilities, Class A Ordinary Shares Subject to Possible Redemption, and Shareholders’ Deficit |
Loading...
